Research analysts at StockNews.com began coverage on shares of Electromed (NYSEAMERICAN:ELMD – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “strong-buy” rating on the medical equipment provider’s stock.
Separately, TheStreet lowered shares of Electromed from a “b-” rating to a “c+” rating in a research note on Monday, July 31st. Three equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $20.50.
Electromed Price Performance
ELMD opened at $10.14 on Friday. The business has a 50 day moving average of $11.67. Electromed has a 1 year low of $9.23 and a 1 year high of $13.84. The firm has a market capitalization of $86.80 million, a PE ratio of 36.21 and a beta of 0.39.
Institutional Trading of Electromed
Institutional investors have recently added to or reduced their stakes in the business. James Investment Research Inc. acquired a new position in shares of Electromed during the first quarter valued at $40,000. Cetera Advisor Networks LLC acquired a new position in shares of Electromed during the second quarter valued at $129,000. Legato Capital Management LLC acquired a new position in shares of Electromed during the fourth quarter valued at $149,000. State Street Corp boosted its holdings in shares of Electromed by 8.3% during the second quarter. State Street Corp now owns 15,736 shares of the medical equipment provider’s stock valued at $152,000 after acquiring an additional 1,207 shares during the period. Finally, Corsair Capital Management L.P. boosted its holdings in shares of Electromed by 14.9% during the first quarter. Corsair Capital Management L.P. now owns 16,634 shares of the medical equipment provider’s stock valued at $173,000 after acquiring an additional 2,152 shares during the period. Institutional investors own 31.74% of the company’s stock.
Electromed Company Profile
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.
Featured Articles
- Five stocks we like better than Electromed
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 07/31 – 08/04
- Video Game Stocks: How to Invest in Gaming
- 3 Best Meme ETFs to Buy Now
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- XPO Keeps Reaching New Highs: Markets Love the Stock
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.
